SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-05-013258
Filing Date
2005-11-03
Accepted
2005-11-03 09:08:38
Documents
9
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c99529e10vq.htm 10-Q 251220
2 THE ELI LILLY AND COMPANY BONUS PLAN, AS AMENDED c99529exv10w1.htm EX-10.1 68911
3 MASTER SETTLEMENT AGREEMENT c99529exv10w2.htm EX-10.2 98516
4 STATEMENT RE: COMPUTATION OF EARNINGS (LOSS) PER SHARE c99529exv11.htm EX-11 12786
5 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS c99529exv12.htm EX-12 9264
6 RULE 13A-14(A) CERTIFICATION OF SIDNEY TAUREL c99529exv31w1.htm EX-31.1 8379
7 RULE 13A-14(A) CERTIFICATION OF CHARLES E. GOLDEN c99529exv31w2.htm EX-31.2 8414
8 SECTION 1350 CERTIFICATION c99529exv32.htm EX-32 5093
9 CAUTIONARY STATEMENT c99529exv99.htm EX-99 9828
  Complete submission text file 0000950137-05-013258.txt   473852
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 051175088
SIC: 2834 Pharmaceutical Preparations